Orlistat as a fatty acid synthase inhibitor blocks cell survival mechanism via activating PTEN, which controls PI3K/AKT/MAPK axis in PC3 prostate cancer cells

Author

Aras, Sahra
Özdemir, Beril Su
Arısan, Elif Damla
Rencüzoğulları, Özge
Özfiliz Kılbaş, Pelin
Obakan Yerlikaya, Pınar
Çoker Gürkan, Ajda
Palavan Ünsal, Zeynep Narçın

Type

Article

Date

2017-08-30

Language

en_US

Metadata

Show full item record

URI

https://doi.org/10.1016/j.jbiotec.2017.06.654
https://hdl.handle.net/11413/2237

Collections

• Makaleler / Articles [140]